Nanomolecular 'smart bombs' seek and destroy cancer cells

October 18, 1999

ANN ARBOR---University of Michigan scientists will receive $4.4 million from the National Cancer Institute to develop an innovative approach to cancer treatment---nanomolecular "smart bombs" that sense pre-malignant and cancerous changes inside living cells and then destroy the cells before they can grow into tumors.

"Our goal is to create a multi-functional therapeutic device small enough to work inside living cells," says James R. Baker Jr., M.D., the project's principal investigator who directs the Center for Biologic Nanotechnology in the U-M Medical School. "The device will target to abnormal cells. If it confirms pre-cancerous lesions, it can release a substance to kill the cell and then verify that the cell is dead."

The U-M project is one of five funded by the NCI's new Unconventional Innovations Program, which supports peer-reviewed, high-risk, high-impact research with the potential to revolutionize cancer care.

"During the last decade, scientists have learned a great deal about biochemical and genetic changes within cells that can lead to cancer," says Allen Lichter, M.D., a cancer specialist and dean of the U-M Medical School. "Now we need to develop new ways to identify and treat these changes at the molecular level long before they can be detected with current technology. Research funded by this National Cancer Institute program could help bring us closer to that goal."

Synthetic polymers called dendrimers will be used as delivery vehicles to transport anti-cancer drugs and sensing agents into cells, according to Baker. "Dendrimers already are used in many biological applications," he says. "They have been shown to readily enter cells, and they have little toxicity when given intravenously."

Fifteen researchers from the U-M Medical School, the U-M College of Engineering and the U-M College of Literature, Science, and the Arts will collaborate on the three-year research project. Working together, these scientists hope to develop new sensing technologies capable of imaging biochemical changes within cells. Researchers in the U-M College of Engineering will concentrate on finding ways to use ultrafast laser or sound wave energy pulses to release anti-cancer drugs stored inside dendrimers.

Others from the U-M Medical School involved in the project include Brian Athey, Ph.D., assistant professor of anatomy and cell biology; Stephen Ethier, Ph.D., associate professor of radiation oncology; James Mulay, Ph.D., professor of surgery and of internal medicine; Donald Tomalia, Ph.D., senior research scientist; Jolanta Kukowska, Ph.D., research investigator; Anna Bielinska, Ph.D., research investigator; and research associates Lajos Balogh, Ph.D., Istvan Majoros, Ph.D., and Lars Piehler, Ph.D.

Collaborators from other U-M colleges include Mark Banaszak-Holl, Ph.D., assistant professor of chemistry; Bradford Orr, Ph.D., associate professor of physics; Emmett Leith, Ph.D., professor of electrical engineering and computer science; Theodore Norris, Ph.D., associate professor of electrical engineering and computer science; Gerard Mourou, Ph.D., professor of electrical engineering and computer science.

The National Cancer Institute is a federal agency and part of the National Institutes of Health.
Contact: Sally Pobojewski
U-M News Service
412 Maynard
Ann Arbor, MI 48109-1399
Phone: (734) 647-1844

University of Michigan

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to